Department of Medical Genetics, Faculty of Medicine, "Grigore T. Popa" University of Medicine and Pharmacy, University Street, No 16, 700115 Iasi, Romania.
Department of Otorhinolaryngology, Faculty of Medicine, "Grigore T. Popa" University of Medicine and Pharmacy, University Street, No 16, 700115 Iasi, Romania.
Genes (Basel). 2020 Dec 15;11(12):1506. doi: 10.3390/genes11121506.
We have investigated the main genetic causes for non-syndromic hearing impairment (NSHI) in the hearing impairment individuals from the North-Eastern Romania and proposed a cost-effective diagnosis protocol.
MLPA followed by Sanger Sequencing were used for all 291 patients included in this study.
MLPA revealed abnormal results in 141 cases (48.45%): 57 (40.5%) were c.35delG homozygous, 26 (18.44%) were c.35delG heterozygous, 14 (9.93%) were compound heterozygous and 16 (11.35%) had other types of variants. The entire coding region of was sequenced and out of 150 patients with normal results at MLPA, 29.33% had abnormal results: variants in heterozygous state: c.71G>A (28%), c.457G>A (20%), c.269T>C (12%), c.109G>A (12%), c.100A>T (12%), c.551G>C (8%). Out of 26 patients with c.35delG in heterozygous state, 38.46% were in fact compound heterozygous.
We identified two variants: c.109G>A and c.100A>T that have not been reported in any study from Romania. MLPA is an inexpensive, rapid and reliable technique that could be a cost-effective diagnosis method, useful for patients with hearing impairment. It can be adaptable for the mutation spectrum in every population and followed by Sanger sequencing can provide a genetic diagnosis for patients with different degrees of hearing impairment.
我们研究了罗马尼亚东北部听力障碍患者中非综合征型听力损失(NSHI)的主要遗传原因,并提出了一种具有成本效益的诊断方案。
对纳入本研究的 291 例患者均采用 MLPA 联合 Sanger 测序。
MLPA 发现 141 例(48.45%)存在异常结果:57 例(40.5%)为纯合 c.35delG,26 例(18.44%)为杂合 c.35delG,14 例(9.93%)为复合杂合子,16 例(11.35%)存在其他类型的变异。对 的整个编码区进行测序,在 MLPA 结果正常的 150 例患者中,29.33%存在异常结果:杂合状态的变异:c.71G>A(28%)、c.457G>A(20%)、c.269T>C(12%)、c.109G>A(12%)、c.100A>T(12%)、c.551G>C(8%)。在 26 例杂合 c.35delG 的患者中,有 38.46%实际上是复合杂合子。
我们发现了两种以前在罗马尼亚的任何研究中都没有报道过的变异:c.109G>A 和 c.100A>T。MLPA 是一种廉价、快速、可靠的技术,可能是一种具有成本效益的诊断方法,对听力障碍患者有用。它可以适应每个人群的突变谱,随后进行 Sanger 测序可以为不同程度听力障碍的患者提供遗传诊断。